Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...

Sickle cell disease causes severe pain that’s hard to treat, but researchers are finding new ways to offer relief ...

HOUSTON - A unique opportunity for a local woman! She is now working with the doctor who helped save her life at The ...

Scientists found that the blood stem cells became functional bone marrow at similar levels to those seen in umbilical cord blood cell transplants. Umbilical cord stem cell transplants are already ...

Hundreds of posters have appeared on billboards across Italy this summer, bearing the slogan: “Russia is not our enemy” and depicting a handshake in the colors of the Italian and Russian flags.

Ty Pendlebury has worked at CNET since 2006. He lives in New York City where he writes about streaming and home audio. Expertise Ty has worked for radio, print, and online publications, and has ...

Two Oral Presentations Featured Updated Ivonescimab Data from Phase II Studies in CRC and TNBC in Addition to Poster ...

A New Ventilator-on-a-Chip Model to Study Lung Damage Sep. 19, 2024 — Scientists are now able to directly compare the different kinds of injury that mechanical ventilation causes to cells in the ...

Induced pluripotent stem cells (iPSCs) are pluripotent stem cells generated from adult cells by reprogramming. iPSCs have the same properties as embryonic stem cells, and therefore self-renew and ...

Biomaterials are revolutionizing organoid development by offering tunable platforms that provide instructive cues, which enhance cell fate transitions, tissue-level functions and reproducibility ...

Stem Cell research got a non-controversial boost by the Senate on Friday when it passed an umbilical cord stem cell bill that avoids the controversy over embryonic stem cells. Stem Cell research got a ...